Effects of Benazepril Hydrochloride in Cats with Experimentally Induced or Spontaneously Occurring Chronic Renal Failure

DOI JASI Web Site Web Site 2 Citations 66 References
  • WATANABE Toshifumi
    Department of Surgery, School of Veterinary Medicine, Azabu University Department of Nephrology and Urology, Teaching Animal Hospital, Azabu University
  • MISHINA Mika
    Department of Nephrology and Urology, Teaching Animal Hospital, Azabu University

Bibliographic Information

Other Title
  • ネコの実験的慢性腎不全モデルおよび自然発症慢性腎不全に対するbenazepril hydrochlorideの効果
  • Internal medicine: Effects of benazepril hydrochloride in cats with experimentally induced or spontaneously occurring chronic renal failure

Search this article

Abstract

We examined effects of an angiotensin converting-enzyme inhibitor, benazepril hydrochloride (BH), on renal hypertension and chronic renal failure (CRF) in cats. For experimental CRF, healthy cats (n=5) underwent 7/8 renal ablation. After renal insufficiency and hypertension were confirmed by blood urea nitrogen (BUN), serum creatinine, creatinine clearance and telemetric recording of systemic blood pressure, BH was administered orally once daily at 0.9 to 2.0 mg/kg/day for 2 to 3 weeks. Within 2 months after renal ablation, renal failure and hypertension developed as evidenced by significant increases in BUN, serum creatinine and systemic blood pressure (p<0.01 or 0.05) and significantly decreased creatinine clearance accompanied by elevated plasma renin activity, angiotensin I and II, and aldosterone (p<0.01 or 0.05). BH administration corrected systemic hypertension (p<0.05) and significantly reduced angiotensin II and aldosterone (p<0.05). Upon discontinuation of BH, these values returned to the pre-administration levels. Studies on spontaneous CRF enrolled 11 cats with spontaneously occurring CRF. BH was administered orally to 6 cats once daily for 24 weeks at a final dose of 1.0 mg/kg/day, while 5 cats served as control. BH administration reduced serum creatinine and urinary protein concentration in every cat. Results demonstrate that in cats, loss of renal mass leads to activation of the renin-angiotensin-aldosterone system and associated renal hypertension, and indicate that BH is effective in correcting renal hypertension and may provide renal benefits to cats with CRF.<br>

Journal

Citations (2)*help

See more

References(66)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top